Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Fat emulsion pre-emulsifying concentrated solution for teniposide intravenous injection and preparation method thereof

A teniposide and pre-emulsification technology, applied in the directions of emulsion delivery, oil/fat/wax inactive ingredients, and inactive medical formulations, etc., can solve problems such as strong side effects, extend the validity period, and increase storage. Effects of stability, ease of transport and storage

Inactive Publication Date: 2010-12-15
PEKING UNIV
View PDF7 Cites 5 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

But as mentioned earlier, both Cremophor EL and Tween 80 have strong side effects

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Fat emulsion pre-emulsifying concentrated solution for teniposide intravenous injection and preparation method thereof
  • Fat emulsion pre-emulsifying concentrated solution for teniposide intravenous injection and preparation method thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0046] Embodiment 1, prescription screening of teniposide injection

[0047] Prepare the solution as above, and observe the result after 8 hours. The prescription composition and screening results of teniposide are shown in Table 1.

[0048] Table 1. Prescription composition and screening results of teniposide

[0049]

[0050]

Embodiment 2

[0052] prescription:

[0053] Teniposide 0.05g

[0054] Lecithin 3.0g

[0055] soybean oil 0.2g

[0056] N,N-Dimethylacetamide 0.3g

[0057] Absolute ethanol 5g

[0058] Preparation:

[0059] Add 0.05g of teniposide into 0.3g of N,N-dimethylacetamide, after it is completely dissolved, add 3g of lecithin, 0.2g of soybean oil and 5g of absolute ethanol, stir to make them evenly mixed Forms a clear, clear pre-emulsion concentrate.

Embodiment 3

[0061] prescription:

[0062] Teniposide 0.05g

[0063] Lecithin 3.0g

[0064] soybean oil 0.2g

[0065] N,N-Dimethylacetamide 0.3g

[0066] Absolute ethanol 5g

[0067] Preparation:

[0068] Teniposide 0.05g is added to the mixed solution of 0.3g of N,N-dimethylacetamide and 0.2g of soybean oil, after completely dissolving, add lecithin 3g and dehydrated alcohol 5g, stir to make They are mixed well to form a clear and clear pre-emulsion concentrate.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
The average particle sizeaaaaaaaaaa
Login to View More

Abstract

The invention belongs to the field of medicinal preparations and discloses fat emulsion pre-emulsifying concentrated solution for teniposide intravenous injection and a preparation method thereof. The fat emulsion pre-emulsifying concentrated solution for teniposide intravenous injection comprises the following components in percentage by weight: 0.01 to 10 percent of teniposide, 0 to 20 percent of oil phase, 10 to 80 percent of phospholipids and 10 to 99 percent of organic solvent for injection. The preparation method comprises the following steps of: dissolving the active ingredient, namely the teniposide, in the organic solvent or the oil phase or the mixture of the organic solvent and the oil phase, adding the other components in the formula into the mixture, and after stirring to uniformly mix the components, obtaining the transparent and clear pre-emulsifying concentrated solution.

Description

technical field [0001] The invention belongs to the field of pharmaceutical preparations, and in particular relates to a formula of fat emulsion pre-emulsified concentrate for intravenous injection of teniposide and a preparation method thereof. Background technique: [0002] Teniposide (Teniposide, Vumon, VM-26) aliases: Wittmann, Vumon 26, thiamin glucoside, Banglai, podophylloside. It is a semi-synthetic derivative of podophyllotoxin, which belongs to the antitumor drug of plant origin. It is a cycle-specific cytotoxic drug that inhibits DNA topoisomerase II, causing double-strand or single-strand damage to stop cell mitosis at late S or G 2 In the early stage, it hinders tumor cell division and inhibits tumor growth. Teniposide has a remarkable curative effect, and its biological activity is 5 to 10 times that of the same type of drug etoposide, and clinical data show that teniposide has few side effects, low toxicity, and has no obvious effect on liver and kidney func...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K9/107A61K31/7048A61K47/24A61K47/44A61K47/14A61K47/18A61P35/00
Inventor 张强代文兵王坚成张烜
Owner PEKING UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com